trovafloxacin has been researched along with methicillin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; Mathialagan, S; Ryu, S; Varma, MVS; Woody, N | 1 |
| Bonilla, HF; Bradley, SF; Kauffman, CA; Zarins, LT | 1 |
| Firsov, AA; Kononenko, OV; Lubenko, IY; Vasilov, RG; Vostrov, SN; Zinner, SH | 1 |
| Eckart, RE; Fishbain, JT; Hospenthal, DR | 1 |
| Järvinen, A; Kardén-Lilja, M; Kuusela, P; Ruotsalainen, E; Sarna, S; Valtonen, V; Virolainen-Julkunen, A; Vuopio-Varkila, J | 1 |
1 trial(s) available for trovafloxacin and methicillin
| Article | Year |
|---|---|
Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Case-Control Studies; Electrophoresis, Gel, Pulsed-Field; Endocarditis, Bacterial; Fluoroquinolones; Genotype; Humans; Methicillin; Middle Aged; Naphthyridines; Ofloxacin; Serologic Tests; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Teichoic Acids | 2008 |
6 other study(ies) available for trovafloxacin and methicillin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Identification of Organic Anion Transporter 2 Inhibitors: Screening, Structure-Based Analysis, and Clinical Drug Interaction Risk Assessment.
Topics: Drug Interactions; HEK293 Cells; Humans; Liver; Organic Anion Transporters, Sodium-Independent; Risk Assessment | 2022 |
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model.
Topics: Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Gram-Negative Bacteria; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Naphthyridines; Staphylococcus aureus | 1999 |
Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.
Topics: Adult; Anti-Infective Agents; Endocarditis, Bacterial; Fluoroquinolones; Humans; Lung Abscess; Male; Methicillin; Methicillin Resistance; Naphthyridines; Penicillins; Staphylococcal Infections | 2000 |